STA® - Liquid Anti-Xa
Assay, Heparin. 510(k) K260214, from Diagnostica Stago, Inc. (Parsippany, NJ). Product code KFF, class 2.
As of Nov 19, 2026, K260214 is an FDA 510(k) held by Diagnostica Stago, Inc., substantially equivalent on Sep 24, 2026 after 244 days, with no recalls tied to it in FDA's recall database.
- Review time: 244 days
- Recalls: 0
STA® - Liquid Anti-Xa: The STA® Liquid Anti-Xa kits are intended for use with STA-R® family, STA Compact® and STA Satellite® analyzers, for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate.
- Sta(R) - Liquid Anti-Xa, Multi Hep Calibrator, Quality Hnf / Ufh, Quality Hbpm / LmwhK111822 · Diagnostica Stago, Inc. · Oct 26, 2011
- HemosIL Liquid Anti-XaK213464 · Instrumentation Laboratory CO · Oct 4, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Jan 23, 2026
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7525
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files